Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention

被引：0

作者：

Chandrasekhar, J. ^{[1
]}

Baber, U. ^{[1
]}

Sartori, S. ^{[1
]}

Aquino, M. ^{[1
]}

Henry, T. ^{[2
]}

Rao, S. ^{[3
]}

Snyder, C. ^{[1
]}

Weintraub, W. ^{[4
]}

Effron, M. ^{[5
]}

Pocock, S. ^{[6
]}

Keller, S. ^{[5
]}

Kini, A. ^{[1
]}

Strauss, C. ^{[7
]}

Mehran, R. ^{[1
]}

Kapadia, S. ^{[8
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[3] Duke Univ, Med Ctr, Chapel Hill, NC USA

[4] Christiana Hosp, Newark, DE USA

[5] Eli Lilly & Co, Indianapolis, IN 46285 USA

[6] London Sch Hyg & Trop Med, London, England

[7] Minneapolis Heart Inst Fdn, Minneapolis, MN USA

[8] Cleveland Clin, Cleveland, OH 44106 USA

来源：

EUROPEAN HEART JOURNAL | 2016年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P5608

引用

页码：1164 / 1164

页数：1

共 50 条

[21] The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention
那堃
ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (01) : 31 - 31
[22] Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?
Giri, Jay
Nathan, Ashwin
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) : 1587 - 1589
[23] Prasugrel A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Duggan, Sean T.
Keating, Gillian M.
DRUGS, 2009, 69 (12) : 1707 - 1726
[24] Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention A Report From the PROMETHEUS Study
Baber, Usman
Chandrasekhar, Jaya
Sartori, Samantha
Aquino, Melissa
Kini, Annapoorna S.
Kapadia, Samir
Weintraub, William
Muhlestein, Joseph B.
Vogel, Birgit
Faggioni, Michela
Farhan, Serdar
Weiss, Sandra
Strauss, Craig
Toma, Catalin
DeFranco, Anthony
Baker, Brian A.
Keller, Stuart
Effron, Mark B.
Henry, Timothy D.
Rao, Sunil
Pocock, Stuart
Dangas, George
Mehran, Roxana
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (20) : 2017 - 2025
[25] Clopidogrel patterns of use in acute coronary syndrome patients undergoing percutaneous coronary intervention in 5 european countries
Mccollam, P.
Bae, J. P.
Nasuti, P.
Yeung, E.
Hamad, B.
EUROPEAN HEART JOURNAL, 2007, 28 : 195 - 195
[26] CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES
McCollam, P. L.
Bae, J. P.
Nasuti, P., I
Anger, C.
VALUE IN HEALTH, 2008, 11 (06) : A415 - A415
[27] Clopidogrel patterns of use in acute coronary syndrome patients undergoing percutaneous coronary intervention in 5 European countries
Smith, H.
McCollam, P. L.
Nasuti, P.
Bae, J. P.
VALUE IN HEALTH, 2006, 9 (06) : A358 - A358
[28] Hospitalization Costs Of Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Comparison Between Clopidogrel And Prasugrel Patients In A US Hospital Database
Bae, Jay
Ernst, Frank
Faries, Douglas
Lipkin, Craig
Moretz, Chad
Zhao, Zhenxiang
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B213 - B213
[29] DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICE
Effron, Mark B.
Molife, Cliff
Karkare, Swapna
Larmore, Cynthia
Zhu, Yajun
Lee, Won Chan
Frech-Tamas, Feride
Lieu, Hsiao
DeKoven, Mitch
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A225 - A225
[30] COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS
Mondragon, R.
Arrieta-Maturino, E.
Vargas-Valencia, J. J.
Martinez-Fonseca, J.
Guzman-Sotelo, M.
Galindo-Suarez, R. M.
Ramirez-Gamez, J.
VALUE IN HEALTH, 2011, 14 (07) : A545 - A545

← 1 2 3 4 5 →